CRISPR-associated (CAS) protein
A new CRISPR-associated (Cas) protein, termed “CasM,” is described, as well as polynucleotides encoding the same and methods of using CasM for site-specific genome engineering. CasM proteins are capable of targeting and cleaving single-stranded RNA.
1. An expression cassette comprising:
a polynucleotide encoding:
a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated (Cas) protein, wherein the Cas protein comprises an amino acid sequence selected from the group consisting of SEQ ID NO:37, SEQ ID NO:39, SEQ ID NO:44, an amino acid sequence having at least 98 percent sequence identity to SEQ ID NO:37, an amino acid sequence having at least 98 percent sequence identity to SEQ ID NO:39, and an amino acid sequence having at least 98 percent sequence identity to SEQ ID NO:44; the polynucleotide is operably linked to a regulatory sequence; and
one or more cognate nucleic acid guides, wherein the one or more cognate nucleic acid guides comprise a repeat sequence and a spacer sequence, wherein the repeat sequence and the spacer sequence do not naturally occur together, wherein the Cas protein is capable of forming one or more nucleoprotein complexes with the one or more cognate nucleic acid guides, and wherein each nucleoprotein complex is capable of site-directed binding to a target nucleic acid sequence.
2. The expression cassette of claim 1 , wherein the Cas protein is catalytically inactive.
3. The expression cassette of claim 1 , further comprising one or more nucleic acid sequences each encoding a nuclear localization tag operably linked to the polynucleotide encoding the Cas protein.
4. The expression cassette of claim 1 , wherein the Cas protein comprises an amino acid sequence having at least 98 percent sequence identity to SEQ ID NO:37.
5. The expression cassette of claim 4 , further comprising one or more nucleic acid sequences each encoding a nuclear localization tag operably linked to the polynucleotide encoding the Cas protein.
6. The expression cassette of claim 1 , wherein the Cas protein comprises an amino acid sequence having at least 98 percent sequence identity to SEQ ID NO:44.
7. The expression cassette of claim 6 , further comprising one or more nucleic acid sequences each encoding a nuclear localization tag operably linked to the polynucleotide encoding the Cas protein.
8. A recombinant vector, comprising:
the expression cassette of claim 1 .
9. The recombinant vector of claim 8 , wherein the Cas protein comprises SEQ ID NO:37 or an amino acid sequence having at least 98 percent sequence identity to SEQ ID NO:37 and further comprises one or more nucleic acid sequences each encoding a nuclear localization tag operably linked to the polynucleotide encoding the Cas protein.
10. The recombinant vector of claim 8 , wherein the Cas protein comprises SEQ ID NO: 44 or an amino acid sequence having at least 98 percent sequence identity to SEQ ID NO: 44 and further comprises one or more nucleic acid sequences each encoding a nuclear localization tag operably linked to the polynucleotide encoding the Cas protein.
11. A eukaryotic cell, comprising:
the expression cassette of claim 1 .
12. The eukaryotic cell of claim 11 , wherein the eukaryotic cell is a mammalian cell.
13. The eukaryotic cell of claim 12 , wherein the eukaryotic cell is a human cell.
14. The expression cassette of claim 1 , wherein the Cas protein comprises a fusion protein.
15. The expression cassette of claim 1 , wherein the the one or more cognate nucleic acid guides are RNA, DNA, or a combination of RNA and DNA.
16. The expression cassette of claim 1 , wherein the regulatory sequence comprises a eukaryotic regulatory sequence.
17. The expression cassette of claim 1 , wherein the regulatory sequence comprises a promoter selected from the group consisting of an inducible promoter, a repressible promoter, and a constitutive promoter.
18. The recombinant vector of claim 8 wherein the vector is a viral vector.
19. The expression cassette of claim 1 , wherein the polynucleotide is codon optimized for expression in a human cell.
20. An expression cassette comprising:
a polynucleotide encoding:
a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated (Cas) protein, wherein the Cas protein comprises an amino acid sequence selected from the group consisting of SEQ ID NO:37, SEQ ID NO:39, SEQ ID NO:44; the polynucleotide is operably linked to a regulatory sequence; and
one or more cognate nucleic acid guides comprising a repeat sequence and a spacer sequence, wherein the repeat sequence and the spacer sequence do not naturally occur together, wherein the Cas protein is capable of forming one or more nucleoprotein complexes with the cognate nucleic acid guide, and wherein each nucleoprotein complex is capable of site-directed binding to a target nucleic acid sequence.
21. The expression cassette of claim 20 , wherein the Cas protein comprises the amino acid sequence of SEQ ID NO: 37.
22. The expression cassette of claim 20 , wherein the Cas protein comprises the amino acid sequence of SEQ ID NO: 39.
23. The expression cassette of claim 20 , wherein the Cas protein comprises the amino acid sequence of SEQ ID NO: 44.
24. The expression cassette of claim 1 , wherein the Cas protein comprises an amino acid sequence having at least 98 percent sequence identity to SEQ ID NO: 39.
25. The expression cassette of claim 1 , wherein the Cas protein comprises the amino acid sequence of SEQ ID NO: 37.
26. The expression cassette of claim 1 , wherein the Cas protein comprises the amino acid sequence of SEQ ID NO: 39.
27. The expression cassette of claim 1 , wherein the Cas protein comprises the amino acid sequence of SEQ ID NO: 44.